Pacific Edge surges; NZX 50 falls

Pacific Edge surges; NZX 50 falls
Dan Brunskill
Shares in cancer diagnostic firm Pacific Edge skyrocketed, climbing more than 20% on a deal with a large US insurer, even as the wider share market edged lower.The S&P/NZX 50 Index fell 58.25 points, or 0.5%, to 12,574.35. Within the index, 23 stocks fell, 21 rose, and six were unchanged. Turnover was $203.1 million.Pacific Edge was the best performer by a wide margin. Investors added $100m, or more than a fifth, to the cancer diagnostic firm’s market capitalisation after its Cxbladder test was approved by the biggest healthcare group...

More Markets

NZ sharemarket drops after weak GDP data
Markets Market Close

NZ sharemarket drops after weak GDP data

Stats NZ data showed NZ's gross domestic product fell 0.9% in the June quarter.

Tom Raynel 18 Sep 2025
Craigs beefs up in Hawkes Bay, eyes further expansion
Finance

Craigs beefs up in Hawkes Bay, eyes further expansion

Craigs looks to further expansion as it confirms the Somerset Smith Partners deal.

Staff reporters 18 Sep 2025
NZ dollar on watch ahead of 3Q GDP, Fed signals
Markets

NZ dollar on watch ahead of 3Q GDP, Fed signals

Economists expect NZ GDP to shrink 0.3% in the June quarter after March growth.

Rebecca Howard 18 Sep 2025
Seeking a faster, sharper ComCom
Economy

Seeking a faster, sharper ComCom

A ‘gold standard’ approach and siloed structure slow the ComCom down.

Pattrick Smellie 18 Sep 2025